A study of the probable transmission routes of MERS-CoV during the first hospital outbreak in the Republic of Korea
Citations Over TimeTop 10% of 2017 papers
Abstract
Infections caused by the Middle East respiratory syndrome coronavirus (MERS-CoV) are a serious health issue due to their prevalence and associated mortality. However, the transmission routes of the virus remain unclear, and thus, the current recommended control strategies are not evidence based. In this study, we investigated the transmission routes of MERS-CoV during the first nosocomial outbreak in the Republic of Korea in May 2015 using a multi-agent modeling framework. We identified seven hypothesized transmission modes based on the three main transmission routes (long-range airborne, close contact, and fomite). The infection risks for each hypothesis were estimated using the multi-agent modeling framework. Least-squares fitting was conducted to compare the distribution of the predicted infection risk in the various scenarios with that of the reported attack rates and to identify the hypotheses with the best fit. In the scenarios in which the index patient was a super-spreader, our model simulations suggested that MERS-CoV probably spread via the long-range airborne route. However, it is possible that the index patient shed an average viral load comparable to the loads reported in the literature, and that transmission occurred via a combined long-range airborne and close contact route.
Related Papers
- → Nipah virus outbreak with person-to-person transmission in a district of Bangladesh, 2007(2010)172 cited
- → The Outbreak of SARS at Tan Tock Seng Hospital – Relating Epidemiology to Control(2006)38 cited
- → Assessing airborne transmission risks in COVID-19 hospitals by systematically monitoring SARS-CoV-2 in the air(2023)6 cited
- → Study of Tuberculosis Outbreaks Reported in Catalonia, 1998–2002(2006)6 cited
- → PP006 [Infections » Covid-19 / Sars-CoV-2]: EVALUATION OF A NEGATIVE PRESSURE AEROSOL PROTECTION BOX TO PREVENT AIRBORNE TRANSMISSION OF SARS-COV-2 TO HEALTHCARE PROVIDERS IN PEDIATRIC INTENSIVE CARE(2022)